Sherry A. Dunbar
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Sherry A.
Contact Sherry A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
For Infectious Disease Testing, Flexibility Is Key
As the role of clinical laboratories grows more prominent in the diagnosis and treatment of patients with infectious diseases, there is mounting pressure on both the labs and the diagnostic tests they select.
Evaluation of the Aries Bordetella Assay for Detection and Identification of Bordetella pertussis in Nasopharyngeal Swab Specimens
Bacteriology T. McMillen, H. Y. Chow, Shubhagata Das, Sherry A. Dunbar, N. E. Babady Daniel J. Diekema, Editor DOI: 10.1128/JCM.01966-18 ABSTRACT The Aries Bordetella assay (Aries BA) (Luminex Corporation) recently received FDA clearance for the detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids in nasopharyngeal swab (NPS) samples.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Sherry A.
Contact Sherry A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack